Bruker Corp
(NAS:BRKR)
$
64.73
0.74 (1.16%)
Market Cap: 9.80 Bil
Enterprise Value: 11.90 Bil
PE Ratio: 26.86
PB Ratio: 5.48
GF Score: 90/100 
Bruker Corp at Barclays Global Healthcare Conference Transcript
Mar 14, 2019 / 02:45PM GMT
Release Date Price:
$38.15
(-0.50%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Great, and thank you everybody. Good morning. Our final presentation for Life Science Tools and Diagnostics. I am Jack Meehan, the analyst at Barclays, pleased to be joined by Bruker's CEO, Frank Laukien. We're going to start with 3 audience response questions. I will ask the question one. What do you view as Bruker's organic growth profile over the next 3 years? You have to wait to give us the answer.
Frank H. Laukien
Bruker Corporation - Chairman, CEO & President
I'm sorry, I'm doing this now or...
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
You will give us the answer later in the presentation.
Frank H. Laukien
Bruker Corporation - Chairman, CEO & President
I see, I see, okay.
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Most, right down the middle,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers